Struck = removed from the bill ·
added = the amendment's new text.
HB 524-FN - AS INTRODUCED SESSION 25-0200 05/02 HOUSE BILL 524-FN AN ACT repealing the New Hampshire vaccine association.
SPONSORS:
Granger,Ulery, Straf.Hills.
2;13 October 20, 2025 2025-3021h 05/07 Amendment to HB 524-FN Amend the title of the bill by replacing it with the following:
Rep.3 AN ACT relative to disbursement of funds by the New Hampshire vaccine association and establishing a committee to study the efficacy of the New Hampshire vaccine association.
Belcher,7 Carr.Amend the bill by replacing all after the enacting clause with the following:
4;9 1 New Paragraph;
Rep.New Hampshire Vaccine Association;
Wherry,Powers Hills.and Duties.
13;Amend RSA 126- Q:5 by inserting after paragraph II the following new paragraph:
Rep.III.
Polozov,Assessments Merr.collected by the association, including funds deposited in the state vaccine purchase fund under RSA 141-C:17-a, shall be disbursed by the end of each fiscal year to the extent practicable and not to exceed 90 days thereafter.
10;2 Vaccine Association;
Rep.Collection of Assessments.
Sirois,Amend Hills.RSA 126-Q:3, V(m) to read as follows:
32;(m) Collect assessments from assessable entities as calculated under RSA 126-Q:4 and annually deposit said assessments, less the association's administrative costs [annually] and reserves, with the state treasurer [to the credit of] for deposit in the vaccine purchase fund established pursuant to RSA 141-C:17-a.
Rep.At the written request of the association following a majority vote of the board of directors, any funds forwarded to the state treasurer for the vaccine purchase fund remaining unexpended for childhood vaccines, shall promptly be returned to the association.
Sellers,3 Graf.Committee Established.
18;I.
Rep.There is established a committee to study the efficacy of the New Hampshire vaccine association.
Sabourin,II. Rock.
30The COMMITTEE:members of the committee shall be as follows:
Health,(a) HumanThree Servicesmembers andof Elderlythe Affairshouse ─────────────────────────────────────────────────────────────────of ANALYSISrepresentatives, Thisappointed billby repealsthe RSAspeaker 126-Q,of relative to the Newhouse Hampshireof vaccinerepresentatives. association.
-(b) -Two -members -of -the -senate, -appointed -by -the -president -of -the -senate. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Explanation:
MatterIII. added to current law appears in bold italics.
MatterMembers removedof fromthe currentcommittee lawshall appearsreceive [inmileage bracketsat andthe struckthrough.]legislative Matterrate whichwhen isattending eitherto (a)the allduties newof orthe (b)committee. repealed and reenacted appears in regular type.
HBIV. 524-FN - AS INTRODUCED 25-0200 05/02 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty Five AN ACT repealing the New Hampshire vaccine association.
BeThe itcommittee Enactedshall bystudy the Senateefficacy and House of Representativesthe inNew GeneralHampshire Courtvaccine convened:association.
1The Repeal.committee may solicit information and testimony from any individual, agency, or entity with experience or expertise relevant to the study.
RSAAmendment 126-Q, relative to theHB New524-FN Hampshire- vaccinePage association,2 is- repealed.V.
2The Effectivemembers Date.of the study committee shall elect a chairperson from among the members.
ThisThe actfirst meeting of the committee shall takebe effectcalled 60by daysthe afterfirst-named itshouse passage.member.
LBAThe 25-0200first Revisedmeeting 3/5/25of HBthe 524-FN-committee FISCALshall NOTEbe ASheld INTRODUCEDwithin AN45 ACTdays repealingof the Neweffective Hampshiredate vaccineof association.this section.
FISCALFour IMPACT:members of the committee shall constitute a quorum.
ThisVI. bill does not provide funding, nor does it authorize new positions.
EstimatedThe Statecommittee Impactshall FYreport 2025its FYfindings 2026and FYany 2027recommendations FYfor 2028proposed $24legislation millionto $24the millionspeaker $24of millionthe decreasehouse inof decreaserepresentatives, inthe decreasepresident inof NHVAthe revenue;senate, the house clerk, the senate clerk, the governor, and the state library on or before November 1, 2026.
NHVA4 revenue;Effective Date.
NHVAI. revenue;
IndeterminableSections Indeterminable1 Indeterminableand Revenue2 $0of increasethis inact increaseshall intake increaseeffect in60 insurancedays insuranceafter insuranceits premiumpassage. tax premium tax premium tax revenue revenue revenue Revenue Fund(s) NH Vaccine Association revenue;
insuranceII. premium tax revenue $24 million $24 million $24 million decrease in decrease in decrease in existing vaccine existing vaccine existing vaccine payments;
payments;The remainder of this act shall take effect upon its passage.
payments;Amendment to HB 524-FN - Page 3 - 2025-3021h AMENDED ANALYSIS This bill directs the New Hampshire vaccine association to disburse funds collected through assessments by the end of each fiscal year to the extent practicable.
Expenditures*The $0bill approximatelyalso approximatelyestablishes approximatelya $194,000committee into newstudy $100,000the inefficacy $100,000 in new general fund new general general fund costs fund costs costs Funding Source(s) NH Vaccine Association revenue, state general funds Appropriations* $0 $0 $0 $0 Funding Source(s) None *Expenditure = Cost of billthe *AppropriationNew =Hampshire Authorizedvaccine fundingassociation. to cover cost of bill METHODOLOGY:
This bill repeals RSA 126-Q, the statute establishing the New Hampshire Vaccine Association (NHVA).
The Department of Health and Human Services states that the NHVA collects payments from approximately 80 commercial payers and third-party administrators, and uses these funds to reimburse the Department for the non-governmental share (approximately 60 percent) of the state's universal vaccine purchasing program for children.
The Department anticipates annual revenue decreases of $24 million as a result of the bill.
State expenditures would decrease by the same amount, as provider sites (hospitals, federally-qualified health centers, etc) would then be responsible for privately purchasing, billing and maintaining immunization inventories for privately-insured patients under the age of 19.
The Department estimates that it will need one temporary, part-time positions to communicate these changes to providers, at a cost of $44,000 in FY26.
In addition, as the Department would no longer receive NHVA reimbursement for immunizations purchased for commercially-insured children, it would need funds to purchase vaccines during public health response activities in case of disease outbreaks, disaster relief efforts, etc.
The Department estimates these costs at $150,000 in FY26 and $100,000 annually in subsequent years.
The Insurance Department estimates that payers save approximately 30 percent off the list price of vaccines by participating in the existing program.
The Department states that if the NHVA is eliminated, health insurers may lose access to these savings, potentially leading to increased health care costs, as insurers would need to pay more for vaccines.
Additionally, insurers might experience increased administrative costs, as they would be required to process claims for the reimbursement of childhood vaccines, which is currently not necessary under the universal purchasing program.
These increased costs could exert upward pressure on premiums and, in turn, may increase the amount of insurance premium tax collected.
AGENCIES CONTACTED:
Departments of Insurance and Health and Human Services